Mentioned
ProShares UltraPro Short QQQ
SQQQ
0.4100 (1.09%)
38.15
38.17
Ann Peng Lim
Ann Peng Lim
Malaysia
10mo
π— π—’π—‘π—§π—›π—Ÿπ—¬ π—¨π—£π——π—”π—§π—˜β€¨β€¨ Markets showed modest improvement in September, buoyed by strength in defensive sectors. Notably, our positions in healthcare - Pfizer ($PFE) and Merck ($MRK) contributed positively, as investors rotated into stable, dividend-paying names amid ongoing macro uncertainty. Both companies delivered reassuring updates, reinforcing confidence in their earnings durability. These gains were partially offset by losses in our hedged position via $SQQQ (ProShares UltraPro Short QQQ) as tech rebounded and the Nasdaq outperformed. While this detracted from short-term performance, we view the hedge as prudent given continued valuation risk in growth-heavy indices. We remain focused on capital preservation and selective risk-taking, maintaining a balanced stance as we head into Q4. Upcoming economic data and central bank signals will be key in shaping our tactical positioning. Best Regards Ann
Not investment advice. The author may have financial interests in the mentioned instruments.
undefined logo
SQQQ
ProShares UltraPro Short QQQ
38.14
0.4100 (1.09%)
1 Mentioned
ProShares UltraPro Short QQQ
SQQQ
ProShares UltraPro Short QQQ
null
.